Rituximab maintenance therapy in diffuse large B-cell lymphoma in a multicenter prospective randomised phase II study

被引：0
|
作者：
Witzens-Harig, M. [1 ]
Benner, A. [2 ]
Rieger, M.
McClanahan, F. [1 ]
Hensel, M.
Neben, K. [1 ]
Dreger, P. [1 ]
Lengfelder, E. [3 ]
Schmidt-Wolf, I [4 ]
Kraemer, A. [1 ]
Ho, A. D. [1 ]
机构：
[1] Univ Heidelberg, Med Klin 5, Heidelberg, Germany
[2] German Canc Res Ctr, D-6900 Heidelberg, Germany
[3] Univ Heidelberg, Med Fac Mannheim, D-6800 Mannheim, Germany
[4] Univ Bonn, CIO, Bonn, Germany
来源：
ONKOLOGIE | 2012年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：86 / 86
页数：1
相关论文
共 50 条
  • [21] Role of Rituximab and Rituximab Biosimilars in Diffuse Large B-Cell Lymphoma
    Coleman, Morton
    Lammers, Philip E.
    Ciceri, Fabio
    Jacobs, Ira A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (04): : 175 - 181
  • [22] Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma
    Assouline, Sarit E.
    Nielsen, Torsten Holm
    Yu, Stephen
    Alcaide, Miguel
    Chong, Lauren
    MacDonald, David
    Tosikyan, Axel
    Kukreti, Vishal
    Kezouh, Abbas
    Petrogiannis-Haliotis, Tina
    Albuquerque, Marco
    Fornika, Daniel
    Alamouti, Sepideh
    Froment, Remi
    Greenwood, Celia M. T.
    Oros, Kathleen Klein
    Camglioglu, Errol
    Sharma, Ayushi
    Christodoulopoulos, Rosa
    Rousseau, Caroline
    Johnson, Nathalie
    Crump, Michael
    Morin, Ryan D.
    Mann, Koren K.
    BLOOD, 2016, 128 (02) : 185 - 194
  • [23] Rituximab purging and maintenance therapy combined with autologous stem cell transplantation in patients with diffuse large B-cell lymphoma
    Zhang, Wei
    Jiao, Li
    Zhou, Dao-Bin
    Shen, Ti
    ONCOLOGY LETTERS, 2010, 1 (04) : 733 - 738
  • [24] A Phase II Randomized Study of Lenalidomide or Lenalidomide and Rituximab As Maintenance Therapy Following R-CHOP Chemotherapy for Patients with High Risk Diffuse Large B-Cell Lymphoma
    Reddy, Nishitha M.
    Simons, Rhea M.
    Caldwell, Meghan E.
    Chen, Heidi
    Jagasia, Madan
    Morgan, David S.
    Park, Steven I.
    Greer, John P.
    Richards, Kristy L.
    BLOOD, 2012, 120 (21)
  • [25] Prognostication of diffuse large B-cell lymphoma in the rituximab era
    Ninan, Mary J.
    Wadhwa, Punit D.
    Gupta, Pankaj
    LEUKEMIA & LYMPHOMA, 2011, 52 (03) : 360 - 373
  • [26] Intensified Rituximab Induction Followed By Rituximab Maintenance For Low Grade B Cell Lymphoma: A Multicenter, Phase II Study
    Yamada, Kyouhei
    Sawamura, Mario
    Shimomura, Takeshi
    Takeuchi, Makoto
    Hanada, Shuichi
    Komeno, Takuya
    Hidaka, Michihiro
    Yano, Takahiro
    Kitano, Kiyoshi
    Yoshida, Isao
    Inoue, Nobumasa
    Horibe, Keizo
    Tomoyuki, Watanabe
    Sunami, Kazutaka
    Nagai, Hirokazu
    BLOOD, 2013, 122 (21)
  • [27] PHARMACOKINETICS OF RITUXIMAB IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
    Rozman, S.
    Grabnar, I.
    Novakovic, S.
    Mrhar, A.
    Novakovic, B. Jezersek
    HAEMATOLOGICA, 2017, 102 : 688 - 688
  • [28] A case of irreversible bradycardia after rituximab therapy for diffuse large B-cell lymphoma
    Ko Ko, Nway Le
    Minaskeian, Nareg
    El Masry, Hicham Z.
    CARDIO-ONCOLOGY, 2020, 6 (01)
  • [29] Differences in Outcomes in Males and Females with Diffuse Large B-Cell Lymphoma with Induction Rituximab and Follicular Lymphoma Treated with Maintenance Rituximab
    Habermann, Thomas M.
    Hong, Fangxin
    Morrison, Vicki A.
    Dakhil, Shaker R.
    Weick, James K.
    Frankel, Stanley R.
    Gascoyne, Randy D.
    Fisher, Richard I.
    Cheson, Bruce D.
    Weller, Edie A.
    Kahl, Brad S.
    Peterson, Bruce A.
    Hochster, Howard S.
    Horning, Sandra J.
    BLOOD, 2012, 120 (21)
  • [30] A case of irreversible bradycardia after rituximab therapy for diffuse large B-cell lymphoma
    Nway Le Ko Ko
    Nareg Minaskeian
    Hicham Z. El Masry
    Cardio-Oncology, 6
12345